학술논문
Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression.
Document Type
Article
Author
Source
Subject
*DISEASE progression
*MULTIPLE sclerosis
*ISOPROSTANES
*MAGNETIC resonance imaging
*BLOOD plasma
*PATIENTS
*
*
*
*
*
Language
ISSN
1352-4585
Abstract
The article presents a study concerning the association of plasma isoprostane levels to disease progression in multiple sclerosis (MS). Patients with clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS), and primary progressive MS (PPMS) underwent magnetic resonance imaging (MRI) and clinical testing, and their plasma levels of 8,12-iso-iPF2alpha-VI were determined. It shows that plasma levels were lower in PPMS patients compared to RRMS and CIS patients.